The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software

Episode 60 of The Digital Health Podcast explores how mRNA technology is being repurposed from COVID-19 vaccines to create personalized cancer immunotherapies. Lucas and Luna break down the science behind neoantigen prediction, the case of Moderna and Merck's melanoma trial showing 44% reduction in recurrence risk, and the logistical hurdles of manufacturing a custom vaccine for each patient within weeks. They discuss how AI-powered tumor sequencing enables this precision, the cost implications (around $100,000 per course), and what this means for the future of oncology. A concrete look at how digital health and genomics are converging to make individualized cancer treatment a reality. #mRNA #CancerVaccines #PersonalizedMedicine #Immunotherapy #Moderna #Merck #Melanoma #Neoantigen #TumorSequencing #AIHealth #DigitalHealth #Oncology #Biotech #Genomics #HealthcareAI #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Antibiotic resistance is one of the most pressing global health threats, and digital health tools are emerging as a critical line of defense. In this episode, Lucas and Luna explore how AI-driven diagnostic platforms are helping clinicians prescribe antibiotics more precisely, reducing the spread of superbugs. They dive into a specific case: a machine learning algorithm developed at a UK hospital that predicts bacterial resistance patterns from routine lab data, cutting inappropriate antibiotic use by 30 percent. Along the way, they discuss the economics of deploying these tools in low-resource settings, the data-sharing challenges that slow adoption, and why this might be one of the highest-ROI applications of health AI. A rare intersection of public health urgency and smart business model design. #AntibioticResistance #Superbugs #AIDiagnostics #DigitalHealth #MachineLearning #ClinicalDecisionSupport #HealthTech #InfectiousDisease #PrecisionMedicine #Microbiology #UKHealthTech #NHS #PublicHealth #HealthAI #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #PodcastEpisode Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna explore how smart inhalers are transforming asthma care by connecting patients and doctors with real-time data. They discuss how companies like Propeller Health and Teva are embedding sensors into inhalers to track medication usage, detect triggers, and reduce emergency visits. The hosts examine a clinical study showing a 50% reduction in asthma-related hospitalizations with smart inhaler use, and consider the challenges of cost, data privacy, and insurance coverage. They also touch on the broader implications for respiratory care and digital health adherence monitoring. Tune in for a focused look at a specific device category that's quietly improving outcomes for millions. #SmartInhalers #AsthmaManagement #PropellerHealth #Teva #DigitalHealth #RespiratoryCare #WearableTech #HealthTech #AdherenceMonitoring #ClinicalStudy #HospitalizationReduction #RemoteMonitoring #HealthData #InsulinPumpAnalogy #BusinessAndTechnology #HealthcareInnovation #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Sepsis kills 11 million people a year globally, often because early symptoms look like the flu. But a new wave of hospital AI systems—trained on continuous vital-sign streams from wearable sensors—is catching it three to six hours before traditional screening tools. In this episode, we dive into the specific algorithms running at Johns Hopkins and the UK's NHS, how they combine heart rate variability, respiratory rate, and temperature trends into a single risk score, and why doctors still hesitate to trust a machine's warning over their own instincts. We also explore the tension between faster detection and alert fatigue—a real problem when the AI flags 40 percent of patients as at risk. No hype, just the numbers: false positive rates, time saved, and what it means for the future of hospital monitoring. #SepsisDetection #AIinHealthcare #WearableSensors #HospitalAI #HealthTech #MachineLearning #JohnsHopkins #NHS #VitalSigns #PredictiveAnalytics #PatientSafety #ClinicalAI #AlertFatigue #HealthInnovation #DigitalHealth #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Continuous glucose monitors were once the exclusive domain of the insulin-dependent diabetic. But in 2026, a wave of consumer-facing CGM companies is marketing them to biohackers, gym-goers, and the simply curious. In this episode, Lucas and Luna look at the numbers behind the shift — from clinical utility to lifestyle gadget. They break down the promise of metabolic insight, the skepticism from the medical establishment, and the thin line between health optimization and health anxiety. Featuring a closer look at the startup Nutrisense, which aims to build a CGM-based nutrition coaching subscription, and the FDA's evolving stance on over-the-counter wearable sensors. Is this the blood-pressure-cuff moment for glucose, or the wellness industry's next overhyped panel? #ContinuousGlucoseMonitor #CGM #Nutrisense #WearableTech #DigitalHealth #MetabolicHealth #Biohacking #Wellness #GlucoseMonitoring #FDA #OverTheCounter #HealthTech #BloodSugar #Nutrition #FexingoBusiness #BusinessPodcast #Business #Technology Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore how artificial intelligence is transforming microbiome analysis. They focus on a specific startup, Viome, which uses RNA sequencing and AI to provide personalized dietary recommendations from a single stool sample. The discussion covers the technology behind metatranscriptomics, how it differs from traditional DNA sequencing, and why this matters for conditions like irritable bowel syndrome and metabolic health. Lucas explains the shift from generic probiotics to targeted interventions, while Luna questions the evidence base and the regulatory path. They also touch on the business model — subscription-based testing — and the challenge of turning complex microbiome data into actionable advice. The episode includes a brief, organic donation segment acknowledging listener support that keeps the show ad-free. Whether you're a health-tech operator or a curious patient, this episode offers a concrete look at how AI is decoding one of the most complex ecosystems in the human body. #Microbiome #AI #Viome #RNASequencing #Metatranscriptomics #DigitalHealth #GutHealth #PersonalizedMedicine #Probiotics #MetabolicHealth #IBD #StoolTest #HealthTech #Bioinformatics #Startup #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Digital twins — virtual replicas of human organs, systems, or even entire bodies — are moving from engineering into medicine. In this episode, Lucas and Luna explore how Dassault Systèmes built a 3D heart model accurate enough to simulate surgical outcomes, and why cardiologists at Boston Children's Hospital are using it to plan complex procedures before entering the OR. They discuss the computational scale (each heart model requires over 100 million data points), the regulatory puzzle (the FDA has approved exactly zero digital twins for clinical use), and the ethical tension: what happens when the simulation disagrees with the doctor? Specific, grounded, and forward-looking — no hype. #DigitalTwins #HealthTech #DassaultSystemes #BostonChildrensHospital #Cardiology #MedicalSimulation #SurgicalPlanning #FDA #ComputationalMedicine #3DModeling #VirtualHeart #HealthcareInnovation #PrecisionMedicine #OrganSimulation #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 53 of The Digital Health Podcast explores the emerging field of digital therapeutics for chronic pain. Lucas and Luna examine how companies like Kaia Health and DarioHealth are using cognitive behavioral therapy, movement tracking, and biofeedback to manage conditions like back pain and fibromyalgia—often replacing or reducing opioid use. They discuss a randomized controlled trial showing a 35% reduction in pain-related disability for users of a prescription digital therapeutic, and what this means for insurers and employers seeking non-pharmacological alternatives. The hosts also weigh the regulatory challenges, including FDA clearance for software-as-a-medical-device, and why some clinicians remain skeptical. A thoughtful look at how software is becoming a legitimate treatment modality for one of medicine's most intractable problems: chronic pain. #DigitalHealth #ChronicPain #DigitalTherapeutics #KaiaHealth #DarioHealth #OpioidCrisis #CognitiveBehavioralTherapy #Biofeedback #FDA #SaMD #Business #Healthcare #FexingoBusiness #BusinessPodcast #Podcast #HealthTech #PainManagement #NonOpioid Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore how startups like Nabla and Abridge are deploying generative AI to automate clinical documentation, cutting physician note-taking time from hours to minutes. They examine the accuracy trade-offs, the integration challenges with existing EHR systems, and why this technology might actually reduce burnout rather than just add another tool. With specific examples from pilot programs at Nuance and Epic, the hosts discuss whether AI-generated notes can pass the 'chart review' test and how HIPAA compliance is shaping the market. Plus: what it means for patients who want to understand their own records. #GenerativeAI #ClinicalNotes #Nabla #Abridge #Nuance #Epic #EHR #HealthTech #Startups #Burnout #HIPAA #MedicalDocumentation #AIinHealthcare #DigitalHealth #FexingoBusiness #BusinessPodcast #Technology #FutureOfMedicine Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore how continuous glucose monitors are moving from a niche diabetes tool to a mainstream wellness device for athletes, biohackers, and the general public. They examine the science behind CGMs, the key players like Abbott and Dexcom, the controversy over using them without medical need, and what the data really shows about glucose variability in non-diabetics. Specific focus on the 2024-2025 boom in prescription-free CGM access through companies like Levels and Nutrisense, and the emerging evidence on personalized nutrition responses. The episode also touches on the FDA's evolving stance and the economics of a potential mass market for wearable biosensors. #ContinuousGlucoseMonitor #CGM #WearableTech #DigitalHealth #Diabetes #Biohacking #Abbott #Dexcom #Levels #Nutrisense #GlucoseMonitoring #HealthTech #Wearables #PersonalizedNutrition #FDA #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 50 of The Digital Health Podcast explores how life and health insurers are using data from wearables like smartwatches and fitness trackers to inform underwriting decisions. Lucas and Luna examine the case of John Hancock, which in 2018 became the first major US life insurer to offer interactive policies tied to wearable data through its Vitality program. They discuss how this shift from reactive claims processing to continuous risk monitoring is reshaping the insurance industry, the privacy concerns it raises, and what it means for consumers who choose to share their step counts, sleep scores, and heart rate data for potential premium discounts. The episode also touches on regulatory scrutiny from state insurance commissioners and the growing market for data brokers specializing in health metrics. If you're building or running a business at the intersection of health tech and insurance, this episode offers a concrete look at how one data stream is changing a trillion-dollar industry. #WearableData #HealthInsurance #LifeInsurance #Underwriting #JohnHancock #VitalityProgram #InsuranceTech #DataPrivacy #ConsumerHealth #Smartwatch #FitnessTracker #RiskAssessment #BehavioralInsurance #DigitalHealth #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 49 of The Digital Health Podcast with Fexingo. Lucas and Luna explore the quietly growing market where health insurers pay for wearable device data — not through employer wellness programs, but via direct incentives, premium discounts, and data-sharing agreements. They break down the specific case of UnitedHealth's Motion program, which offers up to $1,000 per year in rewards for sharing step counts and heart rate data from devices like Garmin and Fitbit. The hosts discuss the privacy trade-offs, the regulatory gray area under HIPAA, and how startups like Vivante Health are building insurance-linked digital health platforms. They also examine why Apple and Google are designing their health APIs to give users granular control over data sharing — and whether that's enough to prevent risk-based pricing. A sharp, skeptical conversation about the monetization of personal health data, without sensationalism. #WearableData #HealthInsurance #UnitedHealth #MotionProgram #Garmin #Fitbit #AppleHealth #DataPrivacy #DigitalHealth #Insurtech #VivanteHealth #HIPAA #PremiumDiscounts #HealthPolicy #Business #FexingoBusiness #BusinessPodcast #TechAndHealth Keep every episode free: buymeacoffee.com/fexingo

Episode 48 of The Digital Health Podcast explores how smartphone photos and computer vision are transforming skin cancer screening. Lucas and Luna break down the FDA-cleared AI from companies like SkinAnalytics and DermTech, the accuracy numbers from a 2025 JAMA Dermatology study, and why dermatologists are split between excitement and skepticism. They discuss how convolutional neural networks trained on millions of dermoscopic images can now detect melanoma with sensitivity above 95 percent, but also the real-world pitfalls like lighting variation and skin tone bias. The hosts talk about the specific workflow at Kaiser Permanente's teledermatology program, where patients upload moles for AI triage before seeing a specialist. A concrete, numbers-driven look at a technology that could shift dermatology from reactive to proactive care. #SkinCancer #AI #ComputerVision #Dermatology #Melanoma #HealthTech #DigitalHealth #FDA #Teledermatology #JAMA #SkinAnalytics #DermTech #KaiserPermanente #MachineLearning #CNN #Business #Technology #FexingoBusiness Keep every episode free: buymeacoffee.com/fexingo

We all have health data now — smartwatches, HRV scores, sleep stages, step counts. But does any of it actually change what we do? In this episode, we drill into a study published in the Journal of the American Medical Informatics Association that tracked 2,400 users across four consumer health platforms. The headline number: only 12 percent of users who received a clinically meaningful health insight — like a suspected sign of atrial fibrillation — followed up with a healthcare provider within 30 days. That's a massive gap between data generation and data-informed action. We talk about what the platforms are doing wrong — and what companies like DarioHealth and a startup called PatientPartner are doing differently. If the whole promise of digital health is that more data leads to better decisions, this study suggests that data alone isn't the problem. The problem is the next step: what happens after the watch buzzes. #HealthData #DigitalHealth #Wearables #Smartwatch #PatientBehavior #HealthInsights #AtrialFibrillation #JAMIA #DarioHealth #PatientPartner #DataToAction #HealthTech #BehavioralScience #Business #Technology #FexingoBusiness #DigitalHealthPodcast #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast with Fexingo, Lucas and Luna explore how remote patient monitoring is transforming post-surgery recovery. They focus on the case of Hinge Health, which has expanded from musculoskeletal therapy to surgical recovery, using wearable sensors and a digital platform to track patients' progress after knee and hip replacements. The hosts discuss a recent study showing a 30% reduction in hospital readmissions for patients using Hinge Health's program compared to standard care. Lucas explains the economics: Hinge Health charges employers and health plans a per-member fee, but its value proposition is lower overall healthcare costs. Luna questions whether patients, especially older ones, will adopt the technology. They also touch on competitors like Physitrack and Sword Health, and the regulatory landscape, including FDA clearance for software as a medical device. The episode provides a concrete look at how digital health is moving from wellness adjunct to core clinical tool. #DigitalHealth #HealthTech #RemotePatientMonitoring #PostSurgery #HingeHealth #Wearables #HealthcareInnovation #HospitalReadmissions #SwordHealth #Physitrack #Business #Technology #Podcast #FexingoBusiness #BusinessPodcast #HealthSoftware #Telemedicine #Recovery Keep every episode free: buymeacoffee.com/fexingo

Prescription digital therapeutics (PDTs) are a new category of software that doctors can prescribe to treat conditions from ADHD to substance use disorder. In this episode, Lucas and Luna explore how companies like Akili Interactive and Pear Therapeutics have navigated FDA clearance, insurance reimbursement, and the tricky transition from app store to pharmacy counter. They break down the numbers behind Akili's EndeavorRx — the first FDA-authorized video game for ADHD — and examine why the path from pilot to prescription remains steep. Along the way, they discuss the role of real-world evidence, the challenges of scaling beyond single indications, and what it means for a product to be 'prescribed' in an era when anyone can download a health app. A focused look at where digital therapeutics stand as of mid-2026. #DigitalTherapeutics #PrescriptionDigitalTherapeutics #AkiliInteractive #PearTherapeutics #EndeavorRx #FDA #ADHD #SubstanceUseDisorder #RealWorldEvidence #Reimbursement #HealthcareInnovation #HealthTech #DigitalHealth #Business #Technology #FexingoBusiness #BusinessPodcast #TheDigitalHealthPodcast Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore how voice biomarkers are being used to detect early signs of Alzheimer's disease. They dive into a groundbreaking study from the University of California, San Francisco, where researchers analyzed speech patterns from over 200 older adults and found that subtle changes in pitch, pauses, and word fluency can predict cognitive decline with 78% accuracy up to five years before clinical diagnosis. The hosts discuss the technology behind voice analysis, the collaboration with Canary Speech, and the challenges of bringing this tool to primary care settings. They also touch on privacy concerns and the potential for voice-based screening to become a routine part of checkups, similar to blood pressure measurements. #DigitalHealth #HealthTech #Alzheimers #VoiceBiomarkers #AI #MachineLearning #DementiaDetection #UCSF #CanarySpeech #Wearables #Diagnostics #SpeechAnalysis #CognitiveHealth #EarlyDetection #HealthcareInnovation #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Nearly every major drug company is now weaving digital tools—wearables, smartphones, and connected sensors—directly into how they test new therapies. In this episode, Lucas and Luna look at why decentralized clinical trials have gone from pandemic workaround to permanent fixture, and what that means for both patients and the business of medicine. They walk through the story of Pfizer's Dora trial in advanced breast cancer, where a smartphone app replaced routine in-person visits for symptom tracking, and how that data is now shaping regulatory conversations at the FDA. The hosts also examine the economics: how virtual trial platforms like Medable and Science 37 have raised hundreds of millions in venture funding, and why the contract research organization business—a $60 billion global industry—is racing to retool. If you're building or investing in digital health, this is a shift you can't ignore. #DigitalHealth #ClinicalTrials #DecentralizedTrials #Wearables #Pfizer #Medable #Science37 #FDAClinicalTrials #Pharmaceuticals #CRO #RemoteMonitoring #PatientData #VentureCapital #HealthTech #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #TheDigitalHealthPodcast Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the emerging field of vocal biomarkers for mental health diagnosis. They dive into how AI-powered voice analysis can detect depression, anxiety, and PTSD by picking up subtle acoustic changes. The episode focuses on a real-world study from the University of Southern California where voice samples achieved 85% accuracy in diagnosing PTSD in military veterans. They discuss the underlying technology, the companies leading the way, and the ethical questions around consent and privacy. Lucas explains how vocal biomarkers work — analyzing pitch, tone, cadence, and jitter — and Luna raises concerns about bias and false positives. The conversation also touches on how this tech is being piloted in virtual therapy platforms like Talkspace and Lyra Health, and what it means for the future of mental health screening. #VocalBiomarkers #MentalHealth #AIHealth #DigitalHealth #VoiceAnalysis #PTSD #Depression #UniversityOfSouthernCalifornia #Talkspace #LyraHealth #HealthTech #Diagnostics #AI #MachineLearning #VirtualTherapy #PrivacyInHealth #BusinessAndTechnology #FexingoBusiness Keep every episode free: buymeacoffee.com/fexingo

Hypertension affects nearly half of US adults, yet most people only get their blood pressure checked during a doctor's visit. In this episode, Lucas and Luna explore how wearable blood pressure monitors — from cuff-based devices to optical sensors — are shifting hypertension management from occasional office readings to continuous, real-world data. They examine the technology behind Aktiia's optical blood pressure monitor, which uses photoplethysmography for calibration-free continuous tracking, and compare it to traditional ambulatory monitoring. The hosts discuss the clinical validation process, the FDA's evolving stance on non-invasive blood pressure wearables, and what this means for primary care, remote patient monitoring, and the trillion-dollar cardiovascular disease market. If you're building in digital health or managing a chronic condition yourself, this episode offers a grounded look at which innovations are real and which are still lab projects. #WearableBloodPressure #Hypertension #Aktiia #DigitalHealth #RemotePatientMonitoring #CardiovascularHealth #FDA #Photoplethysmography #HealthTech #BloodPressureMonitoring #ContinuousMonitoring #Business #Technology #ChronicDiseaseManagement #FexingoBusiness #BusinessPodcast #HealthInnovation #MedTech Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the emerging field of vocal biomarker technology, where companies like Sonde Health and Vocalis Health analyze subtle changes in voice patterns to screen for conditions ranging from depression to COVID-19 and even Parkinson's disease. They break down how a 20-second voice sample can reveal physiological cues invisible to the naked eye, the regulatory pathway these devices are navigating, and why the concept raises important privacy questions. The hosts discuss a specific pilot program where a health insurer used voice analysis to flag early signs of respiratory infection, and what it would take for this tech to become a routine part of primary care. No hype—just the signal. #VoiceBiomarkers #DigitalHealth #SondeHealth #VocalisHealth #Wearables #HealthTech #BusinessPodcast #FexingoBusiness #ArtificialIntelligence #RemotePatientMonitoring #PreventiveMedicine #SpeechAnalysis #ParkinsonsDetection #COVIDScreening #MentalHealthTech #HealthDataPrivacy #RegulatoryPathway #PodcastEpisode Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the messy, high-stakes world of EHR integration for digital health platforms. They focus on a specific case: how a chronic care management startup called Rimidi built a direct bridge into Epic Systems, the dominant EHR used by over 250 million patients in the US. The hosts walk through the technical hurdles, the data-privacy landmines, and the business incentives that make or break these integrations. They discuss Rimidi's decision to embed its hypertension and diabetes workflows directly into the clinician's existing screen rather than creating a separate app — and why that choice matters for adoption. The episode also touches on the broader trend of EHRs becoming platforms, with reference to Apple Health Records and the HL7 FHIR standard. No hype, just the reality of getting software to talk to hospital systems. #EHRIntegration #DigitalHealth #EpicSystems #Rimidi #HealthTech #PrimaryCare #FHIR #PlatformStrategy #ChronicCare #Interoperability #ClinicalWorkflow #DataPrivacy #AppleHealthRecords #HealthIT #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #PodcastEpisode Keep every episode free: buymeacoffee.com/fexingo

Episode 38 of The Digital Health Podcast explores the quiet rise of smart rings—wearables that pack sensors into a jewelry form factor. Lucas and Luna examine how Oura, Samsung, and startups like Circular are competing to track sleep, heart rate, and temperature without a wristband. They dig into the clinical research backing ring-based sleep staging, why insurers are starting to subsidize them for employee wellness programs, and the privacy trade-offs of always-on biometric data stored in the cloud. The hosts also touch on the latest FDA clearance for an atrial fibrillation detection algorithm in a smart ring, and ask whether rings will eventually make smartwatches redundant for health monitoring. Tune in for a focused look at the smallest device in digital health—and why it might have the biggest impact on preventive care. #SmartRings #Oura #SamsungGalaxyRing #CircularRing #WearableTech #SleepTracking #HeartRateMonitoring #DigitalHealth #FDA #AtrialFibrillation #EmployeeWellness #HealthTech #Biometrics #Privacy #PreventiveCare #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore the emerging world of wearable microneedle patches that deliver drugs through the skin without pain. They focus on the specific case of Zosano Pharma's transdermal patch for migraine, which failed in clinical trials in 2021, and contrast it with newer players like Vaxxas and LTS Lohmann that are targeting vaccines and insulin. Lucas breaks down the key engineering challenge: how to make microneedles long enough to penetrate the stratum corneum but short enough to avoid pain receptors. Luna asks whether the FDA's regulatory pathway for combination products is slowing adoption. The hosts also discuss the potential market size: Grand View Research estimates the transdermal drug delivery market could reach $12.3 billion by 2027. They debate whether the biggest win will be in chronic disease management (insulin, GLP-1 agonists) or mass vaccination campaigns. The episode ties the conversation to listener support, noting that independent digital health journalism helps separate real innovation from hype. A focused, technical conversation for anyone interested in how wearables are moving beyond sensors into therapeutics. #DigitalHealth #WearableTech #MicroneedlePatches #DrugDelivery #Transdermal #ZosanoPharma #Vaxxas #LTSLohmann #Migraine #Insulin #GLP1 #FDA #CombinationProducts #Business #Technology #FexingoBusiness #BusinessPodcast #HealthTech Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore how a handful of digital health startups are rethinking the primary care visit from the ground up. The episode focuses on 'ambient listening' AI — software that listens to the patient-clinician conversation and automatically generates clinical notes, diagnoses, and billing codes in real time. They examine the specific case of Abridge, which recently partnered with several major health systems, and discuss the numbers: how much time physicians actually spend on documentation (around 15 minutes per appointment after hours), and how ambient listening aims to cut that to zero. They also touch on the tricky regulatory question — when an AI listens in, who owns the transcript? And what happens when the model makes a clinical error in its note? The hosts treat the topic with a sharp business lens, comparing the unit economics of ambient listening to traditional medical scribes (human scribes cost roughly $15 to $20 per hour; AI scribes are targeting $1 to $2 per visit). The episode closes with a forward-looking question: if the listening is automated, and the note-taking is automated, what part of the doctor-patient relationship becomes the truly human middle? #AmbientListening #AIinHealthcare #PrimaryCare #DigitalHealth #Abridge #MedicalScribes #ClinicianBurnout #HealthTech #Business #FexingoBusiness #BusinessPodcast #DoctorPatient #EHR #Documentation #HealthAI #Startup #Podcast #Technology Keep every episode free: buymeacoffee.com/fexingo

In episode 35 of The Digital Health Podcast, Lucas and Luna unpack the FDA's evolving framework for regulating software-as-a-medical-device (SaMD). They focus on the agency's 2025 guidance on AI/ML-enabled devices and how it affects startups like IDx and Caption Health. Lucas explains the 'predetermined change control plan'—a mechanism that lets algorithms update without full re-clearance. Luna questions whether this really accelerates innovation or just shifts risk. They also discuss the de novo pathway, the 510(k) exemption for low-risk tools, and why some digital health companies are choosing not to pursue FDA clearance at all. A concrete look at regulatory strategy for anyone building or investing in health software. #DigitalHealth #SaMD #FDA #SoftwareAsAMedicalDevice #AIinHealthcare #MedTech #RegulatoryStrategy #IDx #CaptionHealth #PredeterminedChangeControlPlan #510kClearance #DeNovoPathway #Business #Technology #HealthTech #FexingoBusiness #BusinessPodcast #DigitalTherapeutics Keep every episode free: buymeacoffee.com/fexingo

Remote patient monitoring has moved beyond chronic disease management into mainstream primary care. Lucas and Luna examine a specific case: a midsize clinic network in Ohio that deployed cellular-connected blood pressure cuffs and pulse oximeters for 2,000 patients with hypertension. They discuss the early results — a 14 percent reduction in systolic blood pressure over six months — and the operational challenges of integrating device data into electronic health records. The conversation also covers the financial incentives: Medicare's RPM billing codes now reimburse roughly $110 per patient per month, making the model viable for independent practices. But questions remain about equity, data burden, and whether RPM widens or closes the care gap. A grounded look at what's actually working in remote monitoring today, with real numbers and real trade-offs. #RemotePatientMonitoring #PrimaryCare #Hypertension #RPM #Medicare #DigitalHealth #HealthTech #Wearables #BloodPressure #PulseOximetry #EHR #ClinicalOutcomes #HealthcareCosts #HealthEquity #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 33 of The Digital Health Podcast with Fexingo explores how artificial intelligence is analyzing retinal scans to detect signs of diabetic retinopathy, cardiovascular disease, and even Alzheimer's risk years before symptoms appear. Lucas and Luna zero in on the FDA-cleared system from IDx-DR (now LumineticsCore) and the new wave of deep learning models trained on millions of fundus photographs. They discuss the clinical validation data from a 2024 JAMA study, the workflow integration challenges in primary care offices, and why reimbursement codes are the bottleneck for scaling. No hype, just the real metrics: sensitivity above 87% in real-world deployment and the false-positive tradeoffs that keep regulators cautious. If you're following where computer vision meets clinical workflow, this is the episode that cuts through the noise. #AI #RetinalImaging #DiabeticRetinopathy #IDxDR #LumineticsCore #ComputerVision #DeepLearning #FDACleared #JAMA #Screening #PrimaryCare #Ophthalmology #DigitalHealth #HealthTech #Diagnostics #BusinessAndTechnology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore how wearables like the Oura Ring and Apple Watch can detect early signs of viral infections before symptoms appear. They discuss the 2020 study from Stanford that showed temperature changes and heart rate variability shifts preceding COVID-19 symptoms by 2-3 days, and how companies like Fitbit are now building disease-detection algorithms. The hosts drill into the specific physiological signals — resting heart rate, skin temperature, respiratory rate — and why the FDA is treating these as a new class of pre-symptomatic screening tools. They also examine the privacy trade-offs: who owns the infection data? Do employers get access? And what happens when a wearable flags an infection that doesn't exist? The episode unpacks the technology, the regulatory landscape, and the ethical questions that come with turning a consumer gadget into a public health sensor. #Wearables #EarlyInfectionDetection #OuraRing #AppleWatch #Fitbit #FDA #HealthTech #DigitalHealth #Biometrics #HeartRateVariability #SkinTemperature #MachineLearning #Privacy #StanfordStudy #COVID19 #Business #Technology #FexingoBusiness Keep every episode free: buymeacoffee.com/fexingo

Episode 31 of The Digital Health Podcast explores how Oura Ring pivoted from a niche sleep tracker to a corporate wellness platform used by employers like Cisco and Bank of America. Lucas and Luna break down the numbers: Oura's reported 600,000 unit sales by mid-2025, the shift from direct-to-consumer to B2B contracts, and how its FDA-cleared blood oxygen and heart rate sensors crossed the line from gadget to legitimate health tool. They discuss the tension between privacy and data pooling in workplace wellness, and what Oura's success means for the broader wearables market. No fluff, just the strategy behind the Ring's quiet takeover of corporate health programs. #OuraRing #Wearables #EmployerHealth #CorporateWellness #DigitalHealth #BusinessStrategy #HealthTech #SleepTracking #FDA #Cisco #BankOfAmerica #B2B #Privacy #WearableTech #FexingoBusiness #BusinessPodcast #HealthInnovation #LucasAndLuna Keep every episode free: buymeacoffee.com/fexingo

Episode 30 of The Digital Health Podcast with Fexingo dives into how Dexcom turned continuous glucose monitoring from a niche diabetes tool into a mainstream wellness product. Lucas and Luna break down the key strategic moves Dexcom made to pull ahead of Abbott's FreeStyle Libre: the G7 sensor's smaller design, the decision to go direct-to-consumer with over-the-counter sales, and the controversial move to launch 'Dexcom Stelo' for non-diabetic health optimizers. They discuss the market numbers—Dexcom's 38% revenue growth in 2025 versus Abbott's 12% in diabetes care—and what the FDA's loosening of prescription requirements means for the future of wearable diagnostics. If you're in digital health or just watching where the smartwatch replacement cycle goes, this episode gives you the specific competitive dynamics shaping the CGM duopoly. #Dexcom #CGM #ContinuousGlucoseMonitor #AbbottFreeStyleLibre #DiabetesTech #DigitalHealth #Wearables #HealthTech #FDA #OverTheCounter #DexcomStelo #GlucoseMonitoring #WellnessTech #Business #Technology #FexingoBusiness #BusinessPodcast #HealthInnovation Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the explosive growth of continuous glucose monitors beyond diabetes management. Lucas explains how Abbott's Freestyle Libre and Dexcom's G7 are now being marketed to 'health optimizers' and athletes. He breaks down the key numbers: the total addressable market expanding from 30 million diabetics to 400 million pre-diabetics plus millions of wellness consumers. Luna questions the evidence base — does real-time glucose data actually improve outcomes in non-diabetics? Lucas cites early studies from Levels and NutriSense showing behavioral changes but acknowledges the 'data for data's sake' criticism. They discuss the regulatory path: the FDA's 2024 clearance of over-the-counter CGMs and what it means for the category. A focused look at how a medical device is becoming a consumer health gadget and whether the science is keeping up. #ContinuousGlucoseMonitor #CGM #Abbott #Dexcom #FreestyleLibre #DexcomG7 #Levels #NutriSense #Wearables #DigitalHealth #Wellness #HealthTech #FDA #GlucoseMonitoring #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna dig into an escalating regulatory war that most consumers don't even know exists. Fitbit's new sleep apnea detection feature got FDA clearance in March 2026, and Apple's atrial fibrillation algorithm now powers a multi-center clinical trial enrolling 15,000 patients. But behind the headlines, both companies are waging a quiet battle over something much bigger: who gets to own the FDA-cleared claim for 'passive health screening' on a wrist-worn device. Lucas walks through the specific filings, the timing, and the commercial stakes — including why Medicare reimbursement is the real prize. Luna brings up the tension between algorithmic transparency and proprietary hardware, and asks whether either company's data is actually good enough for a doctor to act on. The episode pulls back the curtain on a defensive land grab that will determine how your smartwatch talks to your doctor by 2028. #Fitbit #Apple #Wearables #FDA #SleepApnea #AFib #MedTech #ClinicalTrial #HealthRegulation #Algorithm #Reimbursement #DigitalHealth #PassiveScreening #WristWorn #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 27 of The Digital Health Podcast digs into DarioHealth's playbook: how the company combined FDA-cleared digital therapeutics for diabetes and hypertension with human coaching, and why Wall Street is paying attention. Hosts Lucas and Luna break down Dario's acquisition of Upright, the shift from B2C to B2B2C employer contracts, and the unit economics that make the model work. Plus, a look at the regulatory gray zone when software plus a coach replaces a medication. Specific numbers: Dario's $22 million revenue in 2025, 70% gross margin on software alone, and the 40% engagement drop-off after month three. #DarioHealth #DigitalTherapeutics #DiabetesCoaching #HypertensionManagement #UprightAcquisition #B2B2C #EmployerHealthPlans #FDAWaiver #SoftwareAsMedicalDevice #HealthCoaching #UnitEconomics #PatientEngagement #DigitalHealthPodcast #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #HealthTech #ChronicCareManagement Keep every episode free: buymeacoffee.com/fexingo

Episode 26 of The Digital Health Podcast examines DarioHealth's strategy of combining FDA-cleared digital therapeutics with human coaching to boost engagement and outcomes. Lucas and Luna break down the company's pivot from consumer blood pressure and glucose tracking to a B2B chronic condition management platform. They discuss the 2025 acquisition of digital physical therapy platform Vori Health, how Dario's per-member-per-month pricing works for self-insured employers, and why the blended model of software plus live coaching drives higher activation rates than pure apps. The conversation also touches on the broader trend of digital health companies adding clinical services to their tech stacks, and what it means for competitors like Teladoc and Omada. #DigitalHealth #HealthTech #DarioHealth #DigitalTherapeutics #ChronicCare #Coaching #VoriHealth #B2BHealthcare #EmployerHealth #HealthSoftware #Business #Technology #FexingoBusiness #BusinessPodcast #HealthPodcast #DigitalHealthPodcast #MedTech #ValueBasedCare Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna break down how digital therapeutics actually get approved. Using Pear Therapeutics' reSET-O as a case study, they walk through the FDA's new Software Precertification Pilot, the difference between a wellness app and a regulated digital therapeutic, and why the failure rate for DTx submissions is still above 60 percent. They also explore how companies like Akili Interactive and Big Health are navigating the evidence bar. If you're building in health tech, this episode gives you the regulatory roadmap that most founders get wrong. #DigitalTherapeutics #FDAApproval #PearTherapeutics #reSETO #AkiliInteractive #BigHealth #SoftwarePrecertification #RegulatoryScience #HealthTech #DTx #Business #Technology #HealthcareInnovation #ClinicalTrials #EvidenceBar #FexingoBusiness #BusinessPodcast #TheDigitalHealthPodcast Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna explore how the Apple Watch's FDA-cleared ECG feature fundamentally altered the regulatory pathway for consumer health wearables. They trace the 2018 landmark decision that allowed a mass-market device to claim medical-grade heart rhythm monitoring, and examine the ripple effects on startups like AliveCor and Fitbit. The conversation dives into the practical trade-offs: sensitivity vs. specificity, the burden of false positives, and what the data from over 100 million wearables actually tells cardiologists. Lucas brings the numbers from Apple's own atrial fibrillation study published in the New England Journal of Medicine, while Luna challenges whether FDA clearance is meaningful without peer-reviewed accuracy benchmarks. They also touch on the current regulatory bottleneck at the FDA's Digital Health Center of Excellence, and whether the agency has the bandwidth to vet 200+ new device applications per year. A must-listen for anyone tracking the collision between consumer electronics and regulated medicine. #AppleWatchECG #FDA #WearableHealth #AtrialFibrillation #AliveCor #Fitbit #DigitalHealth #Regulatory #Cardiology #HealthTech #ClinicalValidation #SensitivityVsSpecificity #ConsumerWearables #NEJM #HealthData #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the emerging field of 'exercise is medicine' — where health apps and wearables are being used to prescribe physical activity as a formal treatment. They dig into the evidence behind the concept, the companies leading the charge, and why this isn't just another wellness trend but a potential shift in how doctors approach chronic disease. Specific focus on the 'Exercise Is Medicine' initiative from the American College of Sports Medicine, how Apple Watch and Fitbit are being integrated into clinical workflows, and the startups building prescription-grade movement programs. A look at the data, the regulatory path, and the business model that could make exercise a standard part of your next doctor's visit. #ExerciseIsMedicine #DigitalHealth #Wearables #HealthTech #PrescriptionExercise #ACSM #AppleWatch #Fitbit #Luna #Lucas #Fexingo #Business #BusinessPodcast #FexingoBusiness #HealthcareInnovation #ChronicDisease #PreventiveMedicine #HealthApps Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna unpack the surprisingly complex logistics behind telemedicine prescriptions. They focus on the specific case of Truepill, the digital pharmacy that powered Hims & Hers and Nurx before its collapse in 2025. The hosts walk through how prescriptions flow from an online consultation to a patient's mailbox, the role of pharmacy benefit managers, and why state-by-state licensing still creates friction. They discuss the current regulatory landscape as of May 2026, including the DEA's latest rules on controlled substance e-prescribing and how startups like Honeybee Health are building direct-to-patient dispensing. Listeners will come away understanding the difference between a prescription written and a prescription fulfilled — and why that gap matters for the future of digital health. #Telemedicine #Prescriptions #Truepill #DigitalPharmacy #HimsAndHers #Nurx #HoneybeeHealth #DEA #EPrescribing #PharmacyBenefitManagers #StateLicensing #ControlledSubstances #DirectToPatient #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #DigitalHealth #HealthcareLogistics Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna dive into the quiet operational revolution behind hospital-at-home programs, using Mayo Clinic's advanced care at home program as the anchor. They discuss the specific software infrastructure that makes remote monitoring, medication management, and virtual rounding work at scale — including the real numbers on patient outcomes and cost savings. The episode explores why earlier telemedicine efforts failed, what platforms like Biofourmis and Current Health are doing differently, and why the CMS waiver extension in early 2026 gave hospital-at-home its biggest tailwind yet. A concrete look at how health systems are turning the hospital room into a software-defined space. #HospitalAtHome #MayoClinic #Biofourmis #CurrentHealth #VirtualCare #RemoteMonitoring #HealthSoftware #Telemedicine #CMS #AdvancedCare #DigitalHealth #Wearables #HealthcareCosts #PatientOutcomes #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 20 of The Digital Health Podcast explores a growing legal tightrope: who pays when a wearable or an algorithm misses a diagnosis? Lucas and Luna break down the 2025 case of a consumer-grade ECG patch that failed to flag a cardiac event, and how the FDA, device makers, and doctors are all pointing fingers. They walk through the distinction between software as a medical device and general wellness products, and why the liability gap is widening as more health data flows through apps, not clinics. Specific focus on a Florida lawsuit where a patient sued a smartwatch maker and a telehealth platform after a missed arrhythmia — and how the court ruled. No hot takes, just the legal architecture that every startup building health software needs to understand. #DigitalHealth #HealthTech #MedicalLiability #FDA #Wearables #ECG #Telehealth #SoftwareAsMedicalDevice #GeneralWellness #ProductLiability #HealthData #StartupRisk #Business #Technology #FexingoBusiness #BusinessPodcast #HealthSoftware #Regulation Keep every episode free: buymeacoffee.com/fexingo

The Holter monitor has been the gold standard for cardiac arrhythmia detection since the 1950s. But in the past two years, single-use wearable ECG patches have quietly overtaken it in both diagnostic yield and patient compliance. This episode unpacks the numbers: a 2024 JAMA study showing patches detect 23% more arrhythmias than Holters, and how companies like iRhythm (Zio patch) and Mayo Clinic spinout Preventice Solutions drove the shift. Lucas and Luna explore why adhesive patches with 14-day wear time capture events Holters miss, how reimbursement changed after the CMS expanded CPT codes for extended monitoring in 2023, and what this means for the $7 billion ambulatory cardiac monitoring market. Specific, grounded, and forward-looking. #WearableECG #HolterMonitor #iRhythm #ZioPatch #PreventiceSolutions #CardiacMonitoring #Arrhythmia #DigitalHealth #Diagnostics #JAMA #CMS #Reimbursement #HealthcareInnovation #MedTech #WearableTech #ClinicalValidation #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna examine the battle between Headspace and Calm for corporate wellness contracts, a market worth an estimated $3.4 billion annually. They break down how each company positions its product—Headspace leaning on clinical validation and enterprise features like coaching, Calm betting on brand ubiquity and celebrity content—and why employers are starting to demand proof of ROI measured in reduced healthcare claims. The episode drills into the key number: a 28 percent reduction in anxiety scores Headspace reported in a 2023 employer study, versus Calm's 19 percent reduction in a workplace stress trial. Lucas explains how the competitive dynamics mirror earlier platform wars in fitness tech, and why the winner may be determined not by user satisfaction but by integration with health insurance billing codes. #Headspace #Calm #DigitalHealth #MentalHealth #EmployerWellness #CorporateWellness #MeditationApps #HealthcareROI #HealthTech #BehavioralHealth #Benefits #WorkplaceWellness #ROI #ClinicalValidation #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore a surprising new frontier in digital health: the hearing aid market. With the FDA's over-the-counter rule change now two years old, a wave of startups and tech giants are reimagining hearing aids as consumer wearables. Lucas breaks down how companies like Sony, Jabra, and startup Whisper are using smartphone-based tuning, AI-driven sound processing, and direct-to-consumer pricing to disrupt a market long dominated by a handful of legacy players. He explains the economics: traditional hearing aids cost $2,000 to $7,000 per pair, but OTC models are already under $1,000, with some startups targeting $500. Luna questions whether the sound quality and customization can match prescription devices. The hosts discuss a 2025 JAMA study showing that OTC hearing aids perform comparably to prescription ones for mild to moderate hearing loss. They also look at the broader health implications: untreated hearing loss is linked to cognitive decline and dementia. Lucas argues that the OTC shift isn't just about cheaper hardware—it's about embedding hearing health into the Apple Watch and Android ecosystem, turning every smartphone into a potential hearing diagnostic tool. The episode closes with a look at what this means for public health and the legacy industry's response. #HearingAids #DigitalHealth #OTC #FDA #JAMA #Whisper #Sony #Jabra #CognitiveDecline #Dementia #Wearables #Audiology #Startups #Business #Technology #FexingoBusiness #BusinessPodcast #HealthTech Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore Pear Therapeutics' reSET-O, the first FDA-authorized prescription digital therapeutic for opioid use disorder. They unpack how the app works as a cognitive behavioral therapy delivery system, the clinical trial data behind its 40% reduction in abstinence failure, and the business challenges Pear faced before bankruptcy. This episode drills into one specific case to understand what digital therapeutics means for addiction treatment and why software as medicine has struggled to scale. #DigitalTherapeutics #OpioidCrisis #PearTherapeutics #reSETO #PrescriptionDigitalTherapeutic #CBT #AddictionTreatment #FDA #HealthTech #SoftwareAsMedicine #BehavioralHealth #SubstanceUseDisorder #ClinicalTrial #Reimbursement #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 15 of The Digital Health Podcast digs into a surprising low-tech device that is quietly transforming how pharmaceutical companies and researchers run clinical trials: the connected body weight scale. Lucas and Luna explore how a single company, Withings, transitioned from consumer bathroom scales to FDA-cleared medical devices used in obesity and cardiovascular drug trials. They break down the economics: why a $99 consumer scale can replace a $2,000 clinic visit for data collection, how remote weight monitoring reduces dropout rates by 18 percent in one major trial, and why regulators are now accepting digital scale data as primary endpoints for key indications. The hosts also examine the competitive landscape—BodyTrace, Medidata, and Apple's research framework—and why this unglamorous sensor may be the sleeper hit in decentralized clinical trials. Finally, Lucas and Luna tie the discussion to listener support that keeps the show ad-free. #DigitalHealth #ClinicalTrials #ConnectedScales #Withings #DecentralizedTrials #RemoteMonitoring #ObesityDrugs #CardiovascularTrials #FDA #BodyTrace #Medidata #AppleResearchKit #SmartScale #Telemedicine #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the emerging world of digital therapeutics — software-based treatments that are FDA-cleared to treat medical conditions. They focus on Akili Interactive's EndeavorRx, the first prescription video game for ADHD, and discuss the business challenges facing the digital therapeutic industry: reimbursement, physician adoption, and patient engagement. Lucas explains how Akili pivoted from a prescription-only model to a direct-to-consumer subscription in 2024, and what that shift means for the category's future. They compare EndeavorRx to other digital therapeutic companies like Pear Therapeutics (which filed for bankruptcy in 2023) to illustrate the market's growing pains. The episode closes with a look at what it will take for digital therapeutics to move from niche to mainstream, including potential partnerships with pharma and payers. #DigitalTherapeutics #EndeavorRx #AkiliInteractive #ADHD #PearTherapeutics #FDA #DTx #PrescriptionDigitalTherapeutics #HealthTech #BusinessStrategy #RegulatoryApproval #Reimbursement #PayerAdoption #PharmaPartnerships #Gamification #MentalHealth #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore how Tempus AI is creating an operating system for precision medicine. They break down the company's $6 billion data flywheel, how it processes genomic and clinical data from over 7 million patients, and why its partnership with Natera is expanding liquid biopsy access. The hosts discuss Tempus's unique business model, its 2024 IPO, and the challenges of integrating AI into clinical workflows. They also touch on the competitive landscape, including rivals like Foundation Medicine and Caris Life Sciences, and what Tempus's approach means for the future of personalized cancer care. A thoughtful look at how data infrastructure is reshaping healthcare. #TempusAI #PrecisionMedicine #DigitalHealth #AIinHealthcare #Genomics #LiquidBiopsy #Natera #CancerCare #HealthTech #IPO #DataFlywheel #FexingoBusiness #BusinessPodcast #HealthcareInnovation #ClinicalAI #FoundationMedicine #CarisLifeSciences #PersonalizedMedicine Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna unpack how Masimo, a B2B medical device company founded in 1989, quietly beat Apple, Fitbit, and Garmin to become the first brand to get a prescription pulse oximeter cleared by the FDA for consumer use — the Masimo W1 watch. They trace the story from Masimo's breakthrough in signal extraction technology during the 1990s pulse oximetry patent wars, through the company's decade-long investment in miniaturizing its sensors, to the 2023 FDA clearance and its impact on the $50 billion remote patient monitoring market. Along the way, they explore why clinical-grade accuracy matters for conditions like COPD, sleep apnea, and post-COVID pulse monitoring, and how the W1's 510(k) clearance could reshape FDA's approach to consumer health wearables. The episode also examines the strategic irony: a company that built its reputation suing Big Tech for patent infringement (Apple Watch blood-oxygen sensor ban) is now positioning itself as the trusted alternative for patients and doctors alike. #Masimo #PulseOximeter #Wearables #FDA #RemotePatientMonitoring #COPD #SleepApnea #DigitalHealth #MedicalDevices #SignalExtraction #PatentLaw #AppleWatch #510K #ConsumerHealth #ClinicalAccuracy #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 11 of The Digital Health Podcast with Fexingo dives into the 'Hospital at Home' model — specifically, how the Mayo Clinic and Kaiser Permanente are turning acute care into home-based monitoring. Lucas and Luna unpack the data: a 2025 JAMA study showing 20% lower readmission rates and 30% cost savings for patients enrolled in virtual hospital programs. They explore the tech stack — RPM devices, AI triage algorithms, and the role of broadband access. Plus, a candid look at why adoption has been slow despite the evidence, including regulatory hurdles and physician resistance. If you're in health tech or operations, this is the episode that explains why home-based acute care is scaling now. #HospitalAtHome #VirtualCare #RemotePatientMonitoring #MayoClinic #KaiserPermanente #JAMA #RPM #AcuteCare #DigitalHealth #HealthTech #Telemedicine #AIinHealthcare #Buisness #HealthPolicy #FexingoBusiness #BusinessPodcast #TheDigitalHealthPodcast #HealthInnovation Keep every episode free: buymeacoffee.com/fexingo